This episode explores gene therapy, a revolutionary medical technology that aims to treat or cure diseases by repairing or replacing faulty genes within the human body. After scientists discovered that many illnesses are caused by genetic mutations in DNA, researchers began developing methods to correct these errors at their source rather than simply treating symptoms.
Early gene therapy used modified viruses to deliver healthy genes into cells, allowing them to replace defective instructions responsible for certain inherited diseases. Advances in biotechnology, especially CRISPR gene-editing technology, have made it possible to directly modify DNA with remarkable precision. These breakthroughs have already helped treat conditions such as inherited blindness, immune disorders, and blood diseases like sickle cell anemia.
Despite its promise, gene therapy raises complex ethical questions. Editing genes in adult patients to cure disease is widely supported, but modifying embryos could permanently alter future generations. Concerns about genetic inequality, designer traits, and accessibility also remain significant challenges.
Ultimately, gene therapy represents a major shift in medicine—from managing disease to rewriting the biological instructions of life itself, offering the possibility of curing genetic disorders and transforming the future of healthcare.